Pixium Vision SA develops retinal implant systems. It develops epi-retinal and sub-retinal implant systems to treat patients who have lost their sight, with the intention of improving their vision and enabling them to lead more independent lives. The company was founded by Jose-Alain Sahel, Bernard Gilly, Serge Picaud, Christoph Posch, Philippe Bergonzo and Lionel Rousseau on December 28, 2011 and is headquartered in Paris, France.
Sector:
Health Technology
Industry:
Medical Specialties
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Pixium Vision SA?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Pixium Vision SA market cap is $1.53M.